Cite
Raymond W, Ostli-Eilertsen G, Griffiths S, et al. IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role. Eur J Rheumatol. 2017;4(1):29-35doi: 10.5152/eurjrheum.2017.16059.
Raymond, W., Ostli-Eilertsen, G., Griffiths, S., & Nossent, J. (2017). IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role. European journal of rheumatology, 4(1), 29-35. https://doi.org/10.5152/eurjrheum.2017.16059
Raymond, Warren, et al. "IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role." European journal of rheumatology vol. 4,1 (2017): 29-35. doi: https://doi.org/10.5152/eurjrheum.2017.16059
Raymond W, Ostli-Eilertsen G, Griffiths S, Nossent J. IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role. Eur J Rheumatol. 2017 Mar;4(1):29-35. doi: 10.5152/eurjrheum.2017.16059. Epub 2017 Mar 01. PMID: 28293450; PMCID: PMC5335884.
Copy
Download .nbib